You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Medroxyprogesterone

Showing 1 - 25 of 273
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I Trial in Peking (Medroxyprogesterone acetate + Atorvastatin)

Recruiting
  • Atypical Endometrial Hyperplasia
  • Endometrial Carcinoma Stage I
  • Medroxyprogesterone acetate + Atorvastatin
  • Peking, Beijing, China
    Wang Jianliu
Dec 29, 2022

Abnormal Uterine Bleeding, Tranexamic Acid, Estrogen Trial in Bangkok, Phaya Thai (Tranexamic acid 250 mg oral tablet, Progynova

Not yet recruiting
  • Abnormal Uterine Bleeding
  • +3 more
  • Tranexamic acid 250 mg oral tablet
  • Progynova 1 mg oral tablet
  • Bangkok, Ratchathewi, Thailand
  • +1 more
Sep 27, 2023

Gender Dysphoria, Adolescent Trial in Denver (Depo-subQ Provera Injectable Product)

Recruiting
  • Gender Dysphoria, Adolescent
  • Depo-subQ Provera Injectable Product
  • Denver, Colorado
    Comprehensive Women's Health Center
Feb 13, 2023

Infertility Trial in Istanbul (Gonadotropin releasing hormone antagonist (Cetrotide), Medroxyprogesterone Acetate (Tarlusal),

Not yet recruiting
  • Infertility
  • Gonadotropin releasing hormone antagonist (Cetrotide)
  • +2 more
  • Istanbul, Turkey
    Bezmialem Vakif University
Mar 13, 2023

Contraception Trial (Depot-Medroxyprogestereone Acetate)

Not yet recruiting
  • Contraception
  • Depot-Medroxyprogestereone Acetate
  • (no location specified)
Aug 15, 2022

Photorefractive Keratectomy Trial in Isfahan (prepared drop of medroxy progestrone acetat 1%)

Completed
  • Photorefractive Keratectomy
  • prepared drop of medroxy progestrone acetat 1%
  • Isfahan, Iran, Islamic Republic of
  • +1 more
Jul 26, 2023

Fertility Sparing Trial in Beijing (Medroxyprogesterone Acetate 500 MG Oral Tablet, Levonorgestrel-Releasing Intrauterine

Recruiting
  • Fertility Sparing
  • Medroxyprogesterone Acetate 500 MG Oral Tablet
  • Levonorgestrel-Releasing Intrauterine System
  • Beijing, Beijing, China
    Bei Jing Chao-Yang Hospital
Oct 3, 2022

Contraception Trial in Cypress, San Antonio (TV-46046, DeposubQ Provera)

Active, not recruiting
  • Contraception
  • Cypress, California
  • +2 more
Nov 18, 2022

Menorrhagia Trial in Sherbrooke (MPA, )

Terminated
  • Menorrhagia
  • Sherbrooke, Quebec, Canada
    Centre Hospitalier Universitaire de Sherbrooke
May 16, 2022

Healthy Trial in Brussels (Sayana Press)

Recruiting
  • Healthy
  • Sayana Press
  • Brussels, Bruxelles-capitale, Région DE, Belgium
    Brussels Clinical Research Unit
May 23, 2022

Endometrial Tumor Malignant Stage I Trial in Shanghai (Megestrol Acetate 160 MG Oral Tablet, Medroxyprogesterone Acetate 500 MG,

Recruiting
  • Endometrial Neoplasm Malignant Stage I
  • Megestrol Acetate 160 MG Oral Tablet
  • +3 more
  • Shanghai, Shanghai, China, China
    Obstetrics and Gynecology Hospital, Fudan University
Mar 25, 2022

Uterine Bleeding Trial in Assiut (Tranexamic acid, Medroxyprogesterone Acetate 150 MG/ML)

Recruiting
  • Uterine Bleeding
  • Tranexamic acid
  • Medroxyprogesterone Acetate 150 MG/ML
  • Assiut, Egypt
    Women Health Hospital - Assiut university
Aug 27, 2021

Infertility Trial in Valencia (Provera 10 mg., Ganirelix (GnRH antagonist))

Completed
  • Infertility
  • Provera 10 mg.
  • Ganirelix (GnRH antagonist)
  • Valencia, Spain
    IVI Valencia
Aug 24, 2021

Endometriosis Ovary Trial in Semarang (Dienogest, Depo Medroxyprogesterone acetate, Leuprolide (as Leuprolide Acetate))

Recruiting
  • Endometriosis Ovary
  • Semarang, Central Java, Indonesia
    Kariadi Hospital
Nov 22, 2023

Hormonal Contraceptive Methods on Immunologic Changes in Female

Recruiting
  • Hormonal Contraception
  • Depot medroxyprogesterone acetate (DMPA)
  • +2 more
  • Atlanta, Georgia
  • +2 more
Aug 15, 2022

Arteriovenous Malformations Trial (MedroxyPROGESTERone Injection [Depo-Provera], Other)

Not yet recruiting
  • Arteriovenous Malformations
  • MedroxyPROGESTERone Injection [Depo-Provera]
  • Other
  • (no location specified)
Aug 4, 2022

HRT on Overactive Bladder Symptoms, Sexual Function, Depressive

Recruiting
  • Menopausal Syndrome
  • Tibolone 2.5 mg
  • Estradiol valerate 1 mg/medroxyprogesterone acetate 2.5 mg
  • Banqiao, New Taipei, Taiwan
    Department of Obstetrics and Gynecology, Far Eastern Memorial Ho
Jan 29, 2023

Drug-drug Interactions Between Hormonal Contraceptives and

Recruiting
  • HIV Infections
  • +2 more
  • Etonogestrel (ETG) implant
  • +3 more
  • Johannesburg, South Africa
    Wits Reproductive Health and HIV Institute, Research Centre Clin
Feb 28, 2022

Pregnancy, Contraception Trial in Philadelphia, Norfolk (TV-46046 - 400 mg/mL, TV-46046 - 200 mg/mL, TV-46046 - 300 mg/mL (if

Completed
  • Pregnancy
  • Contraception
  • TV-46046 - 400 mg/mL
  • +2 more
  • Philadelphia, Pennsylvania
  • +1 more
Nov 5, 2021

Menopausal Syndromes Trial in Banqiao (Tibolone, Estradiol & medroxyprogesterone acetate)

Completed
  • Menopausal Syndromes
  • Tibolone
  • Estradiol & medroxyprogesterone acetate
  • Banqiao, New Taipei, Taiwan
    Far Eastern Memorial Hospital
Feb 7, 2022

Medication Compliance, Contraception, Self-Evaluation Trial in Boston (watch an instructional video)

Enrolling by invitation
  • Medication Compliance
  • +2 more
  • watch an instructional video
  • Boston, Massachusetts
    Tufts Medical Center
Oct 29, 2021

Human Immunodeficiency Virus, Contraception, ART Trial in Gaborone (Dolutegravir, Levonorgestrel implant, Depo

Recruiting
  • Human Immunodeficiency Virus
  • +2 more
  • Gaborone, Botswana
    Princess Marina Hospital
Mar 1, 2022

IVF, GnRH Antagonist, PPOS Trial in Shanghai (Progesterone, GnRH Antagonist)

Recruiting
  • IVF
  • +2 more
  • Shanghai, China
    ShangHai JIAI Genetics&IVF Institute
Mar 28, 2022

Quick Start of Highly Effective Contraception

Active, not recruiting
  • IUD
  • +4 more
  • Copper T-380 IUD
  • +3 more
  • West Valley City, Utah
    Planned Parenthood Association of Utah
May 4, 2022

Postmenopausal Women Trial (tibolone, Tibolone 2.5 mg, CE/MPA)

Completed
  • Postmenopausal Women
  • (no location specified)
Feb 2, 2022